Skip to content
DataLookout
Menu

NCT07628608

Safety and User Experience of BP-CBB

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed
    • Enrollment target: estimated 60 to confirmed 58
    • Primary and study completion dates changed from estimate of Dec 1, 2026 to Nov 11, 2026
  2. Notable Eligibility criteria expanded, about 34 words
    • Enrollment closed, study ongoing
    • Site details revised
  3. Notable Recruitment opened
    • Start date changed from estimate of Jul 1, 2026 to Jun 16, 2026
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

To evaluate the safety and tolerability of once daily intake of the novel food ingredient BP-CBB in healthy adults
Timeframe: 8 weeks

Arms and interventions

Test armExperimental

Receives Test product containing BP-CBB

Placebo armPlacebo comparator

Receives Placebo product without BP-CBB

Dietary supplements: BP-CBB, Placebo

Sites

1 site in 1 country

  • Atlantia Clinical TrialsCork, Ireland